Literature DB >> 963531

Aluminium, neurofibrillary degeneration and Alzheimer's disease.

D R Crapper, S S Krishnan, S Quittkat.   

Abstract

Aluminium is neurotoxic and results in the proliferation of 100 A diameter filaments in the cytoplasm of certain neurons. The aluminium concentration for 7 normal human brains was 1-9 +/- 0-7 SD mug/g dry weight (n = 208 samples). The aluminium content of 585 areas sampled in 10 post-mortem cases of Alzheimer's disease ranging in age from 50 to 88 years, in which the diagnosis was based on the specific histological appearances, revealed an elevated aluminium content in some regions. A range of 0-4 - 107-0 mug/g was encountered and 28 per cent of all regions sampled had concentrations in excess of 4 mug/g. Five of 6 cerebral biopsies from patients with Alzheimer's disease also had elevated aluminium content. In 2 additional Alzheimer's brains with neurofibrillary degeneration restricted to certain anatomical areas, elevated aluminium content was found to be associated with neurofibrillary degeneration and not with senile plaques. Furthermore, elevated aluminium content in multiple cortical regions was not found in 2 vascular dementias of the elderly. While the cytotoxic concentration for human neurons is unknown, the cytotoxic concentration for cat's cerebral neurons appears to lie between 4 and 6 mug/g dry weight.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963531     DOI: 10.1093/brain/99.1.67

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  55 in total

1.  Alzheimer's disease: a current review.

Authors:  W J Watson; H S Seiden
Journal:  Can Fam Physician       Date:  1984-03       Impact factor: 3.275

2.  Aluminium may cause senile dementia and bone fragility.

Authors:  B Mjöberg
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

3.  Exposure to aluminium and the subsequent development of a disorder with features of Alzheimer's disease.

Authors:  D P Perl
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-20       Impact factor: 10.154

Review 4.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

5.  Aluminum and Alzheimer's disease.

Authors:  T Johnstone
Journal:  CMAJ       Date:  1992-02-15       Impact factor: 8.262

6.  Some medical applications of the oxford scanning proton microprobe.

Authors:  D J Vaux; G W Grime; F Watt
Journal:  Biol Trace Elem Res       Date:  1987-08       Impact factor: 3.738

7.  Review of epidemiologic studies of aluminium and neurological disorders.

Authors:  G F Craun
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

8.  Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.

Authors:  S Sorbi; P Antuono; L Amaducci
Journal:  Ital J Neurol Sci       Date:  1980-03

9.  Reappraisal of the fine structure of Alzheimer's neurofibrillary tangles.

Authors:  S Yagishita; Y Itoh; W Nan; N Amano
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

10.  Inhibition of corticosterone binding in vitro, in rabbit hippocampus, by chromatin bound aluminum.

Authors:  C Sanderson; D R McLachlan; U De Boni
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.